Study results may help surgeons decide on suitable IOLs

Results of an investigation featured in the European Journal of Ophthalmology could help surgeons determine which IOL to use for each patient.

Related Content:

Articles

U.S. FDA grants orphan drug designation to ADX-2191 from Aldeyra Therapeutics

Application for Genentech’s faricimab accepted by U.S. FDA for treatment of wet AMD and DMO

Expanding the definition of AMD